Repenser la production pharmaceutique dans les pays du Sud et du Nord : colloque de lancement du réseau PharmaGHaSTS (Université Paris Cité et King’s College London)
Le 12 sera l’occasion de lancer le projet PharmaGHaSTS. Ce réseau de recherche réunit des chercheures en sciences sociales critiques qui étudient les produits pharmaceutiques et les technologies associées, notamment les outils diagnostiques et les vaccins, à l’intersection de la santé globale et des sciences, technologies et société (STS).
Lors de la conférence d’ouverture, nous proposerons un dialogue interdisciplinaire et transectoriel sur la production pharmaceutique à partir de deux modèles alternatifs : la production publique de vaccins au Brésil et le projet collectif d’une production de médicaments en tant que biens communs en France.
Financé par l’université Paris-Cité et le King’s College de Londres, le réseau vise à encourager des recherches en sciences sociales et des dialogues avec des acteurs non académiques pour comprendre les dysfonctionnements du système actuel, qui ne parvient pas à répondre aux besoins de la majorité de la population mondiale, et pour explorer des modèles alternatifs de recherche, de développement et de fabrication de produits pharmaceutiques susceptibles de promouvoir l’équité et la justice en matière de santé.
A noter : l’évènement est en anglais
Lien pour l’inscription ICI
PROGRAMME
- 16 h - Introduction et lancement du réseau PharmaGHaSTS (KAMEDA DE FIGUEIREDO CARVALHO Koichi Ceped/IRD, Univ. Paris Cité & Anne Pollock, King’s College London)
- 16 h 15 - 17 h 15 : « Pharma Public & Biens Communs : un dialogue avec des acteurs du Sud et du Nord » (participantes : Patricia Neves, Bio-Manguinhos/Fondation Oswaldo Cruz & Gaëlle Krikorian, Communs pharmaceutiques ; introduction : KAMEDA DE FIGUEIREDO CARVALHO Koichi ; modération : Anne Pollock).
- 17 h 30 - 19 h : Cocktail avec lancement des livres ’Technoscientific Globalisation from Below’ et ’Big Bad Pharma’.
Rethinking Pharmaceutical Production in the Global South and North : Launch conference for the PharmaGHaSTS network (Paris Cité University and King’s College London)
Launch symposium for the PharmaGHaSTS network (University of Paris Cité and King’s College London)
March 12th will mark the launch of the PharmaGHaSTS project. This research network brings together critical social science researchers studying pharmaceutical products and related technologies, including diagnostic tools and vaccines, at the intersection of global health, science, technology and society (STS).
During the opening event, we will initiate an interdisciplinary and cross-sectoral dialogue on pharmaceutical production, exploring two alternative models : public vaccine production in Brazil and the collective initiative to produce medicines as common goods in France.
Funded by Université Paris Cité and King’s College London, the network aims to encourage social science research and facilitate dialogue with non-academic stakeholders to address the shortcomings of the current system, which fails to meet the needs of the majority of the global population. The network will also explore alternative models of pharmaceutical research, development and manufacturing that can promote health equity and justice.
PROGRAMME
- 4pm – Introduction and launch of the PharmaGHaSTS network (Koichi Kameda, Ceped/IRD, Univ. Paris Cité & Anne Pollock, King’s College London)
- 4:15pm-5:15pm - ‘Pharma Public & Commons : a dialogue with actors from the South and the North’ (guests : Patricia Neves, Bio-Manguinhos/Oswaldo Cruz Foundation & Gaëlle Krikorian, Communs pharmaceutiques ; Intro by KAMEDA DE FIGUEIREDO CARVALHO Koichi and Facilitation by Anne Pollock).
- 5:30 p.m. – 6:30 p.m. : Cocktail reception, featuring toasts to the books ’Technoscientific Globalisation from Below’ ; ’Big Bad Pharma’.
Speakers’ bios :
- KAMEDA DE FIGUEIREDO CARVALHO Koichi Research Fellow, French National Research Institute for Sustainable Development (IRD) and University of Paris City, affiliated with the Centre for Population and Development (CEPED). He is a sociologist, lawyer and STS scholar whose research focuses on technological autonomy and health sovereignty ; the contributions of actors in the Global South to technological globalisation ; equitable pharmaceutical R&D models for various sociotechnical objects (e.g. vaccines, diagnostics and phage therapy) ; and global health policies in emerging countries. He is the co-editor of the book Technoscientific Globalisation from Below (Mattering Press 2025), alongside Mathieu Quet, Jessica Pourraz and Yves-Marie Raoult-Chodankar.
- Anne Pollock, Professor of Global Health and Social medicine, King’s College London. A scholar in the interdisciplinary field of science and technology studies, her research explores feminist, antiracist, and postcolonial engagements with science, technology, and medicine. Two intertwining threads of her research focus on the impact of racism on health and the social science of pharmaceuticals, with a particular interest in endeavours to realise the potential of pharmaceutical research, development, manufacturing, and distribution to better serve public good. She is the author of : Medicating Race : Heart Disease and Durable Preoccupations with Difference (Duke 2012) ; Synthesizing Hope : Matter, Knowledge, and Place in South African Drug Discovery (Chicago 2019) ; and Sickening : Anti-Black Racism and Health Disparities in the United States (Minnesota 2021).
- Gaëlle Krikorian is a sociologist, political adviser and activist who campaigns for access to medicines. She is currently the coordinator of Communs Pharmaceutiques and has previously worked for Act Up and as an adviser for the Green Party at the European Parliament. She was also the head of policy for the Access to Essential Medicines Campaign at MSF. She is the author of two books : Des Big Pharma aux communs : petit vade-mecum critique de l’économie des produits pharmaceutiques (Lux Éditeur 2022), and Big Bad Pharma, ça suffit ! Changer l’économie du médicament pour mieux soigner, with Médecins du Monde (Editions Eyrolles 2025).
- Patricia Neves, a biologist, is Head of RNA Product Development at Bio-Manguinhos, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. She works at the intersection of biotechnology, immunology and public health innovation and has over 18 years’ experience in immunology, as well as in the development of vaccines and biologicals. She is leading the implementation of the Regional mRNA Vaccine Technology Transfer Hub for Latin America, a joint initiative of the World Health Organization (WHO) and the Pan American Health Organization (PAHO). She is also an Honorary Associate Professor at the University of New South Wales.